Skip to main content
CODX
NASDAQ Industrial Applications And Services

Co-Diagnostics Draws Second $1M J.J. Astor Tranche at 1.35x Factor, Netting $960K

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.14
Mkt Cap
$1.361M
52W Low
$0.128
52W High
$13.54
52W Position info
9.7% above low
Off High info
99% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

CODX is trading near its 52-week low of $0.128 (9.7% above the low).

Summary

Co-Diagnostics drew the second $1.0 million J.J. Astor tranche, issuing a $1.35 million note with a 35% original issue discount and netting $960,000. The note requires $45,000 weekly payments starting November 25, 2026, and failure to complete the reverse split by November 24, 2026 is an event of default.


Key Events · Financing and Capital Events · CODX

  • Second $1M Tranche Funded

    J.J. Astor funded $1.0 million on November 18, 2026 and received a $1.35 million senior secured convertible note — a 1.35x factor rate. After the $40,000 origination fee, Co-Diagnostics netted $960,000.

  • Weekly Payments Start November 25

    The note requires 30 weekly installments of $45,000 beginning November 25, 2026, with a final maturity of June 16, 2027 — roughly $1.35 million of total payments against $960,000 of cash received.

  • Reverse Split Is a Default Trigger

    The lender waived the $1.00 minimum closing price and the reverse-split condition to fund early, but the company must effect the reverse split by November 24, 2026 or it is in default under the note.

  • Conversion at 90% of Lowest VWAP

    The lender converts at 90% of the lowest 10-day VWAP, with a floor at 20% of the Nasdaq minimum price that resets every six months. On default, principal rises to 120% and converts at 80% of the lowest 10-day VWAP.


Analysis · CODX · Industrial Applications And Services

Co-Diagnostics borrowed the second $1.0 million tranche from J.J. Astor and issued a $1.35 million note — a 35% original issue discount that costs the company $350,000 in principal for $1.0 million funded, and $960,000 after the $40,000 origination fee. The cash is general working capital for a company that ended Q3 with $714,803 and reaffirmed going-concern doubt, so this buys weeks, not quarters: 30 weekly payments of $45,000 start November 25, 2026 and run to June 16, 2027. The lender also waived the $1.00 minimum closing price and the reverse-split condition to fund early, but the company must still effect the 1-for-25 reverse split by November 24, 2026 or it is in default — a hard deadline two trading days after this filing. Conversion at 90% of the 10-day lowest VWAP, with a floor that resets every six months, means the lender converts at a discount to market and the share count grows as the stock falls.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CODX was trading at $0.14 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.4M. The 52-week trading range was $0.13 to $13.54. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CODX - Latest Insights

CODX
Nov 19, 2026, 5:00 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.1657
Real-time Price: $0.1301 info
Change: Reverse Stock Split info
Market Cap: $1.361M info
CODX
Nov 13, 2026, 5:00 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.2585
Real-time Price: $0.1301 info
Change: Reverse Stock Split info
Market Cap: $1.361M info
CODX
Nov 10, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.2856
Real-time Price: $0.1301 info
Change: Reverse Stock Split info
Market Cap: $1.361M info
CODX
Nov 10, 2026, 8:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.3652
Real-time Price: $0.1301 info
Change: Reverse Stock Split info
Market Cap: $1.361M info
CODX
Nov 04, 2026, 4:45 PM EST
Filing Type: S-3
Importance Score:
8
Price at Filing: $0.3615
Real-time Price: $0.1301 info
Change: Reverse Stock Split info
Market Cap: $1.361M info